| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 25 |
| 1 | TACROLIMUS | 24 |
| 2 | PEGINTERFERON ALFA-2A | 23 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 4 | TACROLIMUS OINTMENT 0.1% | 22 |
| 5 | MYCOPHENOLIC ACID | 20 |
| 6 | MYCOPHENILIC ACID | 18 |
| 7 | GLECAPREVIR AND PIBRENTASVIR | 12 |
| 8 | DARUNAVIR | 10 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICOTROKINRA | 1 | 0.0023 |
| 1 | DARUNAVIR ETHANOLATE AND COBICISTAT | 3 | 0.0017 |
| 2 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 4 | 0.0015 |
| 3 | MARAVIROC | 3 | 0.0013 |
| 4 | GLECAPREVIR AND PIBRENTASVIR | 12 | 0.0011 |
| 5 | DARUNAVIR 600 MG | 6 | 0.0010 |
| 6 | MYCOPHENILIC ACID | 18 | 0.0008 |
| 7 | CHLORAMBUCIL | 3 | 0.0008 |
| 8 | RILPIVIRINE | 5 | 0.0007 |
| 9 | DARUNAVIR | 10 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 1 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 14 | 0.0009 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 18 | 0.0008 |
| 3 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 4 | Hepatitis C Virus NS5A Inhibitor [EPC] | 20 | 0.0004 |
| 5 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 23 | 0.0004 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0003 |
| 9 | Nucleoside Analog Antiviral [EPC] | 25 | 0.0003 |